How did STRATA Skin Sciences' revenue and expenses trend in Q4 2024?

In Q4 2024, STRATA Skin Sciences experienced a decline in revenue and an increase in certain expenses, resulting in a negative net income. 1. **Revenue Trend**: The company's revenue for Q4 2024 was $21.17 million. This represents a decrease from the previous quarter's revenue, indicating a downward trend in sales. 2. **Expense Trend**: The operating expenses for the same period were $5.92 million. This figure is significantly higher than the R&D expenses of $200,000, suggesting that a large portion of the expenses are related to selling, general, and administrative costs. 3. **Net Income**: The net income for Q4 2024 was -$4.5 million. This negative figure indicates that the company incurred more expenses than it generated in revenue during the quarter. |code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code| |---|---|---|---|---|---|---| |SSKN|SSKN.O|STRATA Skin Sciences|20240101-2024|Dermatology Procedures Equipment|1.2391E7|186| |SSKN|SSKN.O|STRATA Skin Sciences|20240101-2024|Dermatology Procedures Equipment|8570000|186| |SSKN|SSKN.O|STRATA Skin Sciences|20240101-2024|Dermatology Procedures Equipment|5154000|186| |SSKN|SSKN.O|STRATA Skin Sciences|20240101-2024|Dermatology Procedures Equipment|2058000|186| |SSKN|SSKN.O|STRATA Skin Sciences|20240101-2024|Dermatology Procedures Equipment|2058000|186| |SSKN|SSKN.O|STRATA Skin Sciences|20240101-2024|Dermatology Recurring Procedures|4696000|186| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |SSKN|SSKN.O|STRATA Skin Sciences|2024 Q1|-18.800705467372133|-3368000|186| |SSKN|SSKN.O|STRATA Skin Sciences|2024 Q2|96.8551461245235|-99000|186| |SSKN|SSKN.O|STRATA Skin Sciences|2024 Q3|-101.51946818613484|-2122000|186| |SSKN|SSKN.O|STRATA Skin Sciences|2024 Q4|-18.52925672113864|-4497000|186| |code|Ticker|Name|Date|Selling, General, and Administrative Expenses|R&D Expenses|Selling, General, and Administrative Expenses YoY|Operating Expenses YoY|Operating Expenses|R&D Expenses YoY|market_code| |---|---|---|---|---|---|---|---|---|---|---| |SSKN|SSKN.O|STRATA Skin Sciences|20240331|5728000|241000|-13.981078239975972|||-23.49206349206349|186| |SSKN|SSKN.O|STRATA Skin Sciences|20240630|5224000|199000|-11.547578733491365|||-46.79144385026738|186| |SSKN|SSKN.O|STRATA Skin Sciences|20240930|6717000|243000|26.235669986844577|||-2.0161290322580645|186| |SSKN|SSKN.O|STRATA Skin Sciences|20241231|5923000|200000|6.185012549300825|||-47.368421052631575|186| The data suggests that STRATA Skin Sciences faced challenges in Q4 2024, with declining revenue and increased expenses, leading to a substantial loss. The company's focus on reducing costs, particularly in selling, general, and administrative expenses, may be necessary to improve its financial performance in the future.